Apricus Biosciences Announces Transfer Of The United Kingdom Marketing Authorization For Vitaros To Ferring Pharmaceuticals
Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Ferring Pharmaceuticals, the Company’s new partner... Read More